Innovative Technology Advanced Oncotherapy's LIGHT system, developed with CERN technology, represents a cutting-edge and cost-effective proton radiotherapy solution, offering a competitive edge in cancer treatment technologies.

Funding Momentum The company has demonstrated active investment engagement, securing multiple financings totaling over 20 million dollars, indicating strong investor confidence and potential for further capital supports for market expansion.

Market Expansion Potential With the ability to treat patients in major city centers worldwide, the LIGHT system offers scalable deployment opportunities in urban hospitals, appealing to health systems seeking advanced yet affordable oncology solutions.

Growth & Development Recent funding rounds have been dedicated to advancing manufacturing and technology development, presenting opportunities to collaborate in the procurement of new systems or upgrade existing facilities.

Industry Positioning Compared to larger competitors like IBA, Advanced Oncotherapy's focus on innovation and affordability positions it as a disruptive player in the proton therapy market, ideal for strategic partnerships and early adoption programs.